Survival rates increase with chemotherapy alone in patients with limited-stage Hodgkin's lymphoma
Monday, December 12, 2011 - 12:02
in Health & Medicine
New research led by the NCIC Clinical Trials Group (CTG) at Queen's University has proven patients with limited stage Hodgkin's lymphoma have a better chance of long-term survival if they undergo a standard chemotherapy regimen as opposed to radiation-based treatment.